Mylan (MYL), Theravance Biopharma (TBPH) Commence TD-4208 Phase 3 in COPD

September 14, 2015 8:14 AM EDT Send to a Friend
Theravance Biopharma, Inc. (Nasdaq: TBPH) and Mylan N.V. (Nasdaq: MYL) announced the initiation of a Phase 3 program for revefenacin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login